25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Manhattan Scients
Buy, Hold or Sell?

Let's analyze Manhattan Scients together

I guess you are interested in Manhattan Scients. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Manhattan Scients. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Manhattan Scients

I send you an email if I find something interesting about Manhattan Scients.

1. Quick Overview

1.1. Quick analysis of Manhattan Scients (30 sec.)










1.2. What can you expect buying and holding a share of Manhattan Scients? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.4%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0007 - $0.0008
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Manhattan Scients (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-0.01 - $0.00
Total Value Per Share
$-0.01 - $0.00

2.2. Growth of Manhattan Scients (5 min.)




Is Manhattan Scients growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.3m-$1.7m-$739.7k-29.6%

How much money is Manhattan Scients making?

Current yearPrevious yearGrowGrow %
Making money-$264k-$302.2k$38.2k14.5%
Net Profit Margin-4,775.0%400.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Manhattan Scients (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Manhattan Scients?

Welcome investor! Manhattan Scients's management wants to use your money to grow the business. In return you get a share of Manhattan Scients.

First you should know what it really means to hold a share of Manhattan Scients. And how you can make/lose money.

Speculation

The Price per Share of Manhattan Scients is $0.0008. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Manhattan Scients.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Manhattan Scients, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Manhattan Scients.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-35.3%0.00-59.0%0.00-73.4%0.00-45.2%0.00-67.7%
Usd Book Value Change Per Share0.00-35.3%0.000.1%0.00-62.4%0.00-13.6%0.00-3.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-35.3%0.000.1%0.00-62.4%0.00-13.6%0.00-3.2%
Usd Price Per Share0.00-0.00-0.01-0.01-0.03-
Price to Earnings Ratio-1.06--1.51--6.97--2.84--3.64-
Price-to-Total Gains Ratio-4.25--4.25--31.87--26.33--20.39-
Price to Book Ratio-0.29--0.64--2.74-5.62-0.10-
Price-to-Total Gains Ratio-4.25--4.25--31.87--26.33--20.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0008
Number of shares1250000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (1250000 shares)1.12-135.78
Gains per Year (1250000 shares)4.47-543.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104-60-543-553
209-20-1086-1096
301320-1629-1639
401860-2172-2182
5022100-2716-2725
6027140-3259-3268
7031180-3802-3811
8036220-4345-4354
9040260-4888-4897
10045300-5431-5440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%9.031.00.022.5%14.078.06.014.3%
Book Value Change Per Share1.03.00.025.0%1.09.02.08.3%4.013.03.020.0%8.029.03.020.0%26.063.09.026.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.098.00.0%
Total Gains per Share1.03.00.025.0%1.09.02.08.3%4.013.03.020.0%8.029.03.020.0%26.063.09.026.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Manhattan Scients compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.000-31700%0.000+77%0.000-62%0.000-91%
Book Value Per Share---0.004-0.004+7%-0.003-25%0.000-89%0.005-189%
Current Ratio--0.0190.031-39%0.111-83%0.281-93%0.889-98%
Debt To Asset Ratio--32.64918.683+75%3.090+957%4.918+564%2.755+1085%
Debt To Equity Ratio----0%-0%2.240-100%1.381-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---1706862.723-1087798.968-36%1790070.406-195%5913390.095-129%15840573.174-111%
Eps--0.0000.000+67%-0.001+108%0.000+28%-0.001+92%
Ev To Ebitda Ratio--2.667inf+inf%-2.263+185%nannan%nannan%
Ev To Sales Ratio--infinfnan%infnan%nannan%nannan%
Free Cash Flow Per Share--0.0000.000+62%0.000+379%0.000+364%0.000+829%
Free Cash Flow To Equity Per Share--0.0000.000+76%0.000+482%0.000+301%0.000+1151%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.004--------
Intrinsic Value_10Y_min---0.006--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max---0.001--------
Intrinsic Value_3Y_min---0.003--------
Intrinsic Value_5Y_max--0.000--------
Intrinsic Value_5Y_min---0.004--------
Market Cap447424.819-50%671137.2771593951.032-58%4418320.406-85%8084940.095-92%17569423.174-96%
Net Profit Margin----47.7500%4.002-100%-18.9840%-67.1730%
Operating Margin----24.0000%-3.7970%-9.0190%-72.8850%
Operating Ratio---24.125-100%4.042-100%6.988-100%139.042-100%
Pb Ratio-0.191+33%-0.287-0.639+123%-2.735+854%5.623-105%0.095-401%
Pe Ratio-0.708+33%-1.062-1.507+42%-6.971+556%-2.837+167%-3.636+242%
Price Per Share0.001-50%0.0010.003-58%0.008-85%0.014-92%0.031-96%
Price To Free Cash Flow Ratio-6.580+33%-9.870-15.790+60%-13.444+36%-23.273+136%-14.929+51%
Price To Total Gains Ratio-2.832+33%-4.248-4.253+0%-31.866+650%-26.327+520%-20.390+380%
Quick Ratio--0.0160.021-24%0.078-80%1.358-99%1.423-99%
Return On Assets---2.135-1.936-9%-0.340-84%-0.570-73%-0.382-82%
Return On Equity----0%-0%0.699-100%0.327-100%
Total Gains Per Share--0.0000.000-31700%0.000+77%0.000-62%0.000-91%
Usd Book Value---2342000.000-2498000.000+7%-1758250.000-25%-251200.000-89%2657175.000-188%
Usd Book Value Change Per Share--0.0000.000-31700%0.000+77%0.000-62%0.000-91%
Usd Book Value Per Share---0.004-0.004+7%-0.003-25%0.000-89%0.005-189%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---1706862.723-1087798.968-36%1790070.406-195%5913390.095-129%15840573.174-111%
Usd Eps--0.0000.000+67%-0.001+108%0.000+28%-0.001+92%
Usd Free Cash Flow---17000.000-27500.000+62%-81500.000+379%-79750.000+369%-149925.000+782%
Usd Free Cash Flow Per Share--0.0000.000+62%0.000+379%0.000+364%0.000+829%
Usd Free Cash Flow To Equity Per Share--0.0000.000+76%0.000+482%0.000+301%0.000+1151%
Usd Market Cap447424.819-50%671137.2771593951.032-58%4418320.406-85%8084940.095-92%17569423.174-96%
Usd Price Per Share0.001-50%0.0010.003-58%0.008-85%0.014-92%0.031-96%
Usd Profit---158000.000-264000.000+67%-302250.000+91%-116600.000-26%-178125.000+13%
Usd Revenue---500.000-100%-10250.0000%8700.000-100%30825.000-100%
Usd Total Gains Per Share--0.0000.000-31700%0.000+77%0.000-62%0.000-91%
 EOD+2 -6MRQTTM+15 -17YOY+16 -165Y+12 -2110Y+13 -20

3.3 Fundamental Score

Let's check the fundamental score of Manhattan Scients based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.708
Price to Book Ratio (EOD)Between0-1-0.191
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.016
Current Ratio (MRQ)Greater than10.019
Debt to Asset Ratio (MRQ)Less than132.649
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.135
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Manhattan Scients based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.850
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Manhattan Scients

Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-12-02 22:57:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Manhattan Scients earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Manhattan Scients to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Manhattan Scients:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-4,775.0%+4,775.0%
TTM-4,775.0%YOY400.2%-5,175.2%
TTM-4,775.0%5Y-1,898.4%-2,876.6%
5Y-1,898.4%10Y-6,717.3%+4,818.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.4%+6.4%
TTM-4,775.0%-14.9%-4,760.1%
YOY400.2%-15.4%+415.6%
5Y-1,898.4%-17.9%-1,880.5%
10Y-6,717.3%-21.7%-6,695.6%
4.3.1.2. Return on Assets

Shows how efficient Manhattan Scients is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Manhattan Scients to the Medical Devices industry mean.
  • -213.5% Return on Assets means that Manhattan Scients generated $-2.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Manhattan Scients:

  • The MRQ is -213.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -193.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-213.5%TTM-193.6%-19.9%
TTM-193.6%YOY-34.0%-159.6%
TTM-193.6%5Y-57.0%-136.6%
5Y-57.0%10Y-38.2%-18.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-213.5%-2.1%-211.4%
TTM-193.6%-3.2%-190.4%
YOY-34.0%-4.0%-30.0%
5Y-57.0%-3.0%-54.0%
10Y-38.2%-4.0%-34.2%
4.3.1.3. Return on Equity

Shows how efficient Manhattan Scients is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Manhattan Scients to the Medical Devices industry mean.
  • 0.0% Return on Equity means Manhattan Scients generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Manhattan Scients:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y69.9%-69.9%
5Y69.9%10Y32.7%+37.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.4%+2.4%
TTM--3.9%+3.9%
YOY--4.5%+4.5%
5Y69.9%-4.0%+73.9%
10Y32.7%-5.5%+38.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Manhattan Scients.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Manhattan Scients is operating .

  • Measures how much profit Manhattan Scients makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Manhattan Scients to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Manhattan Scients:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2,400.0%+2,400.0%
TTM-2,400.0%YOY-379.7%-2,020.3%
TTM-2,400.0%5Y-901.9%-1,498.1%
5Y-901.9%10Y-7,288.5%+6,386.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.1%+13.1%
TTM-2,400.0%-20.1%-2,379.9%
YOY-379.7%-13.7%-366.0%
5Y-901.9%-16.5%-885.4%
10Y-7,288.5%-20.9%-7,267.6%
4.3.2.2. Operating Ratio

Measures how efficient Manhattan Scients is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Manhattan Scients:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM24.125-24.125
TTM24.125YOY4.042+20.083
TTM24.1255Y6.988+17.137
5Y6.98810Y139.042-132.053
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.203-1.203
TTM24.1251.305+22.820
YOY4.0421.328+2.714
5Y6.9881.366+5.622
10Y139.0421.312+137.730
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Manhattan Scients.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Manhattan Scients is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.02 means the company has $0.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Manhattan Scients:

  • The MRQ is 0.019. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.031. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.019TTM0.031-0.012
TTM0.031YOY0.111-0.080
TTM0.0315Y0.281-0.250
5Y0.28110Y0.889-0.608
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0192.567-2.548
TTM0.0312.666-2.635
YOY0.1112.888-2.777
5Y0.2813.435-3.154
10Y0.8893.527-2.638
4.4.3.2. Quick Ratio

Measures if Manhattan Scients is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Manhattan Scients to the Medical Devices industry mean.
  • A Quick Ratio of 0.02 means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Manhattan Scients:

  • The MRQ is 0.016. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.021. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.016TTM0.021-0.005
TTM0.021YOY0.078-0.057
TTM0.0215Y1.358-1.337
5Y1.35810Y1.423-0.065
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0161.442-1.426
TTM0.0211.678-1.657
YOY0.0781.892-1.814
5Y1.3582.299-0.941
10Y1.4232.555-1.132
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Manhattan Scients.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Manhattan Scients assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Manhattan Scients to Medical Devices industry mean.
  • A Debt to Asset Ratio of 32.65 means that Manhattan Scients assets are financed with 3,264.9% credit (debt) and the remaining percentage (100% - 3,264.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Manhattan Scients:

  • The MRQ is 32.649. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 18.683. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ32.649TTM18.683+13.966
TTM18.683YOY3.090+15.593
TTM18.6835Y4.918+13.765
5Y4.91810Y2.755+2.163
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ32.6490.401+32.248
TTM18.6830.401+18.282
YOY3.0900.362+2.728
5Y4.9180.431+4.487
10Y2.7550.453+2.302
4.5.4.2. Debt to Equity Ratio

Measures if Manhattan Scients is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Manhattan Scients to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Manhattan Scients:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.240-2.240
5Y2.24010Y1.381+0.859
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.565-0.565
TTM-0.600-0.600
YOY-0.531-0.531
5Y2.2400.635+1.605
10Y1.3810.712+0.669
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Manhattan Scients generates.

  • Above 15 is considered overpriced but always compare Manhattan Scients to the Medical Devices industry mean.
  • A PE ratio of -1.06 means the investor is paying $-1.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Manhattan Scients:

  • The EOD is -0.708. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.062. Based on the earnings, the company is expensive. -2
  • The TTM is -1.507. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.708MRQ-1.062+0.354
MRQ-1.062TTM-1.507+0.445
TTM-1.507YOY-6.971+5.464
TTM-1.5075Y-2.837+1.329
5Y-2.83710Y-3.636+0.800
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.708-0.971+0.263
MRQ-1.062-1.329+0.267
TTM-1.507-1.812+0.305
YOY-6.971-2.324-4.647
5Y-2.837-2.144-0.693
10Y-3.636-1.957-1.679
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Manhattan Scients:

  • The EOD is -6.580. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.870. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.790. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.580MRQ-9.870+3.290
MRQ-9.870TTM-15.790+5.921
TTM-15.790YOY-13.444-2.346
TTM-15.7905Y-23.273+7.482
5Y-23.27310Y-14.929-8.344
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-6.580-1.470-5.110
MRQ-9.870-1.900-7.970
TTM-15.790-2.233-13.557
YOY-13.444-5.444-8.000
5Y-23.273-4.008-19.265
10Y-14.929-4.828-10.101
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Manhattan Scients is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -0.29 means the investor is paying $-0.29 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Manhattan Scients:

  • The EOD is -0.191. Based on the equity, the company is expensive. -2
  • The MRQ is -0.287. Based on the equity, the company is expensive. -2
  • The TTM is -0.639. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.191MRQ-0.287+0.096
MRQ-0.287TTM-0.639+0.352
TTM-0.639YOY-2.735+2.096
TTM-0.6395Y5.623-6.261
5Y5.62310Y0.095+5.528
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1912.119-2.310
MRQ-0.2872.142-2.429
TTM-0.6392.344-2.983
YOY-2.7353.005-5.740
5Y5.6234.023+1.600
10Y0.0954.497-4.402
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Total Other Income Expense Net -43-39-82-21-103-87-1901922



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets74
Total Liabilities2,416
Total Stockholder Equity-2,342
 As reported
Total Liabilities 2,416
Total Stockholder Equity+ -2,342
Total Assets = 74

Assets

Total Assets74
Total Current Assets45
Long-term Assets29
Total Current Assets
Cash And Cash Equivalents 38
Other Current Assets 7
Total Current Assets  (as reported)45
Total Current Assets  (calculated)45
+/-0
Long-term Assets
Long Term Investments 27
Long-term Assets Other 2
Long-term Assets  (as reported)29
Long-term Assets  (calculated)29
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,416
Long-term Liabilities1,058
Total Stockholder Equity-2,342
Total Current Liabilities
Short-term Debt 60
Short Long Term Debt 60
Accounts payable 156
Other Current Liabilities 2,180
Total Current Liabilities  (as reported)2,416
Total Current Liabilities  (calculated)2,456
+/- 40
Long-term Liabilities
Long-term Liabilities  (as reported)1,058
Long-term Liabilities  (calculated)0
+/- 1,058
Total Stockholder Equity
Common Stock559
Retained Earnings -72,955
Accumulated Other Comprehensive Income -559
Other Stockholders Equity 70,613
Total Stockholder Equity (as reported)-2,342
Total Stockholder Equity (calculated)-2,342
+/-0
Other
Capital Stock559
Cash and Short Term Investments 38
Common Stock Shares Outstanding 559,281
Current Deferred Revenue20
Liabilities and Stockholders Equity 74
Net Debt 22
Net Invested Capital -3,340
Net Working Capital -2,371
Short Long Term Debt Total 60



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
3,096
3,371
2,715
3,684
3,684
3,594
3,312
2,897
2,897
2,375
2,291
1,646
1,372
1,399
1,326
1,646
1,372
1,598
1,420
1,303
1,303
1,142
1,111
1,170
1,170
810
728
594
511
1,274
1,194
722
479
1,251
594
722
1,019
912
1,141
890
890
779
714
1,927
2,048
2,538
2,045
2,105
2,367
2,205
2,067
1,853
1,853
2,487
2,071
1,861
1,861
2,932
2,355
3,633
17,618
16,032
14,231
12,869
11,190
9,514
8,532
7,635
7,635
15,284
14,584
10,846
10,846
6,966
6,247
2,660
2,660
1,872
3,175
2,225
2,225
2,150
4,024
6,848
6,848
4,555
3,486
3,454
3,454
1,364
1,364
1,031
1,031
569
432
316
91
74
74913164325691,0311,0311,3641,3643,4543,4543,4864,5556,8486,8484,0242,1502,2252,2253,1751,8722,6602,6606,2476,96610,84610,84614,58415,2847,6357,6358,5329,51411,19012,86914,23116,03217,6183,6332,3552,9321,8611,8612,0712,4871,8531,8532,0672,2052,3672,1052,0452,5382,0481,9277147798908901,1419121,0197225941,2514797221,1941,2745115947288101,1701,1701,1111,1421,3031,3031,4201,5981,3721,6461,3261,3991,3721,6462,2912,3752,8972,8973,3123,5943,6843,6842,7153,3713,096
   > Total Current Assets 
923
1,253
620
0
1,619
367
251
0
163
122
266
93
96
225
195
93
96
139
85
333
333
333
387
513
513
259
229
158
128
943
915
496
0
0
158
496
696
605
841
596
596
502
446
1,206
1,336
948
499
604
912
794
702
0
534
1,259
710
590
590
1,759
1,216
2,528
9,556
8,217
6,825
5,364
3,925
2,491
1,759
1,112
1,112
616
452
278
278
136
244
98
98
542
450
574
574
771
780
665
665
764
673
547
547
400
296
189
189
61
90
69
60
45
456069906118918929640054754767376466566578077157457445054298982441362782784526161,1121,1121,7592,4913,9255,3646,8258,2179,5562,5281,2161,7595905907101,25953407027949126044999481,3361,20644650259659684160569649615800496915943128158229259513513387333333333851399693195225969326612216302513671,61906201,253923
       Cash And Cash Equivalents 
858
703
508
0
1,520
194
136
0
79
90
228
68
77
150
68
68
77
87
40
116
116
185
207
364
364
201
214
149
96
885
872
452
0
0
149
452
567
229
626
362
362
278
329
1,055
1,271
723
257
157
715
661
465
91
91
1,111
640
578
578
1,759
1,212
2,528
9,556
8,213
6,656
5,364
3,925
2,491
1,729
1,068
1,068
599
452
269
269
130
242
87
87
230
144
261
261
459
474
353
353
452
366
232
232
386
288
175
175
52
89
67
51
38
385167895217517528838623223236645235335347445926126114423087872421302692694525991,0681,0681,7292,4913,9255,3646,6568,2139,5562,5281,2121,7595785786401,11191914656617151572577231,2711,055329278362362626229567452149004528728859614921420136436420718511611640877768681507768228907901361941,5200508703858
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
129
129
376
215
151
151
151
97
65
65
75
43
32
43
43
43
22
22
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,936
5,875
5,875
3,784
0
0
0
0
0
0
0
0
0
0
0
0
0000000000003,7845,8755,8752,93600000000000000000000000000000222243434332437565659715115115121537612912900000000000000000000000000000000000
       Net Receivables 
10
510
86
0
87
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
0
0
0
0
0
171
0
0
86
0
257
20
0
0
150
0
0
0
0
0
0
0
0
0
30
44
44
14
0
0
0
0
0
0
0
300
300
300
300
300
300
302
300
300
300
300
300
0
0
0
0
0
0
0
0
0
00000000030030030030030030230030030030030030000000001444443000000000015000202570860017100000430000000000000000000000000000000000008708651010
       Other Current Assets 
55
40
26
12
229
173
115
84
100
4
38
25
19
75
127
25
19
52
45
217
217
148
180
149
149
58
15
9
32
58
43
44
44
27
9
44
129
376
215
83
83
30
20
86
65
150
199
244
154
90
108
164
164
128
70
12
12
0
4
0
0
4
169
0
0
0
0
0
0
3
0
9
9
6
2
11
11
12
6
13
13
12
6
312
-5,563
12
307
0
547
14
8
0
14
9
1
0
9
7
79019140814547030712-5,56331261213136121111269903000000169400401212701281641641089015424419915065862030838321537612944927444443583291558149149180148217217455219251277519253841008411517322912264055
   > Long-term Assets 
2,173
2,118
2,095
0
2,065
3,227
3,061
0
2,734
2,253
2,025
1,553
1,276
1,174
1,131
1,553
1,276
1,459
1,335
970
970
809
724
657
657
551
499
436
383
331
279
226
0
0
436
226
323
307
300
294
294
277
268
721
712
1,590
1,546
1,501
1,455
1,411
1,365
0
1,319
1,228
1,361
1,271
1,271
1,173
1,139
1,105
8,062
7,815
7,406
7,505
7,265
7,023
6,773
6,523
6,523
14,668
14,132
10,568
10,568
6,830
6,003
2,562
2,562
1,330
2,725
1,651
1,651
1,379
3,244
6
6,183
3,791
2,813
2,907
2,907
964
1,068
842
842
508
342
247
31
29
29312473425088428421,0689642,9072,9072,8133,7916,18363,2441,3791,6511,6512,7251,3302,5622,5626,0036,83010,56810,56814,13214,6686,5236,5236,7737,0237,2657,5057,4067,8158,0621,1051,1391,1731,2711,2711,3611,2281,31901,3651,4111,4551,5011,5461,590712721268277294294300307323226436002262793313834364995516576577248099709701,3351,4591,2761,5531,1311,1741,2761,5532,0252,2532,73403,0613,2272,06502,0952,1182,173
       Property Plant Equipment 
72
78
116
147
147
136
129
113
113
93
70
56
36
36
36
56
36
50
50
50
50
49
44
43
43
41
41
30
29
29
29
28
28
29
30
28
283
275
268
0
290
0
265
0
248
58
55
50
45
42
37
32
32
22
196
147
147
131
138
144
204
347
324
291
264
236
200
5,889
165
41
8
5,038
8
7
7
1,200
6
6
6
4
4
7
6
6
6
5
5
4
4
2
2
1
1
0
0
0
0
0
00000112244556667446661,2007785,0388411655,8892002362642913243472041441381311471471962232323742455055582480265029002682752832830292828292929304141434344495050505036563636365670931131131291361471471167872
       Goodwill 
0
0
0
0
0
0
685
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
563
563
563
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000056356356300000000000000000000000000685000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
2
2
2
2
2
9,248
8,885
5,505
3,106
2,132
2,777
1,354
1,140
722
2,117
1,045
408
1,070
2,936
5,875
6,199
3,784
2,806
2,901
2,444
960
1,064
839
576
506
340
245
29
27
27292453405065768391,0649602,4442,9012,8063,7846,1995,8752,9361,0704081,0452,1177221,1401,3542,7772,1323,1065,5058,8859,248222220222222220000000022000000000000000000000000000000000000000000000
       Intangible Assets 
2,094
2,033
1,972
0
1,911
2,540
1,728
2,204
2,204
1,886
1,727
1,379
1,229
1,130
1,087
1,379
1,229
922
870
818
818
714
662
610
610
506
454
402
350
298
246
194
142
653
402
194
290
275
268
290
290
273
265
257
248
1,528
1,487
1,447
1,406
1,365
1,324
1,283
1,283
1,202
1,161
1,120
1,120
1,038
997
957
916
875
834
793
753
712
671
630
630
41
33
23
23
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000005232333416306306717127537938348759169579971,0381,1201,1201,1611,2021,2831,2831,3241,3651,4061,4471,4871,5282482572652732902902682752901944026531421942462983504024545066106106627148188188709221,2291,3791,0871,1301,2291,3791,7271,8862,2042,2041,7282,5401,91101,9722,0332,094
       Long-term Assets Other 
0
0
0
0
0
0
512
0
322
0
0
0
44
44
44
41
8
50
413
150
100
44
16
45
2
2
2
32
381
31
31
30
0
0
2
2
31
30
30
2
2
2
1
462
462
2
2
2
2
2
2
0
2
2
2
2
2
2
2
2
6,940
6,591
6,246
6,419
6,246
6,073
5,900
5,891
2
2
2
5,040
5,032
4,686
3,219
8
1,202
602
602
2
602
302
302
2
302
2
2
2
2
2
2
2
2
2
2
2
2
2
2222222222222302230230260226026021,20283,2194,6865,0325,0402225,8915,9006,0736,2466,4196,2466,5916,9402222222202222224624621222303031220030313138132222451644100150413508414444440003220512000000
> Total Liabilities 
461
382
694
816
816
788
1,082
1,385
1,385
1,395
1,595
2,279
1,954
1,968
2,125
2,279
1,954
2,527
2,734
3,099
3,099
3,149
3,405
2,832
2,832
3,033
3,098
2,978
3,043
3,779
4,086
1,795
1,724
1,812
2,978
1,795
1,861
1,816
1,833
1,738
1,738
1,848
1,990
1,856
2,217
2,068
1,850
2,068
2,575
2,825
2,721
2,650
2,650
3,681
3,903
3,041
4,099
4,694
4,465
4,465
4,551
4,695
4,035
4,275
4,435
4,670
5,039
3,854
4,912
2,456
2,366
1,627
2,685
3,004
2,803
1,752
2,810
2,999
3,073
3,230
3,230
3,359
3,448
1,116
2,174
2,330
2,417
2,419
2,419
2,592
2,663
2,726
2,726
2,913
3,038
3,176
2,275
2,416
2,4162,2753,1763,0382,9132,7262,7262,6632,5922,4192,4192,4172,3302,1741,1163,4483,3593,2303,2303,0732,9992,8101,7522,8033,0042,6851,6272,3662,4564,9123,8545,0394,6704,4354,2754,0354,6954,5514,4654,4654,6944,0993,0413,9033,6812,6502,6502,7212,8252,5752,0681,8502,0682,2171,8561,9901,8481,7381,7381,8331,8161,8611,7952,9781,8121,7241,7954,0863,7793,0432,9783,0983,0332,8322,8323,4053,1493,0993,0992,7342,5271,9542,2792,1251,9681,9542,2791,5951,3951,3851,3851,082788816816694382461
   > Total Current Liabilities 
461
382
694
816
816
788
1,082
1,385
1,385
1,395
1,595
2,279
1,954
1,968
2,125
2,279
1,954
2,527
2,734
3,099
3,099
3,149
3,405
2,832
2,832
3,033
3,098
2,978
3,043
3,779
4,086
1,795
1,724
1,812
2,978
1,795
1,861
1,816
1,833
1,738
1,738
1,848
1,990
1,081
1,461
1,312
1,081
1,292
1,792
2,053
1,943
1,952
1,952
1,962
2,457
1,754
1,754
2,116
1,856
1,791
1,812
1,891
1,165
1,289
1,434
1,604
1,908
1,714
1,714
1,398
1,308
1,627
1,627
1,946
1,745
1,752
1,752
1,941
2,015
2,094
2,094
2,210
2,293
1,012
1,012
1,155
1,235
1,361
1,361
1,534
1,605
1,668
1,668
1,855
1,980
2,118
2,275
2,416
2,4162,2752,1181,9801,8551,6681,6681,6051,5341,3611,3611,2351,1551,0121,0122,2932,2102,0942,0942,0151,9411,7521,7521,7451,9461,6271,6271,3081,3981,7141,7141,9081,6041,4341,2891,1651,8911,8121,7911,8562,1161,7541,7542,4571,9621,9521,9521,9432,0531,7921,2921,0811,3121,4611,0811,9901,8481,7381,7381,8331,8161,8611,7952,9781,8121,7241,7954,0863,7793,0432,9783,0983,0332,8322,8323,4053,1493,0993,0992,7342,5271,9542,2792,1251,9681,9542,2791,5951,3951,3851,3851,082788816816694382461
       Short-term Debt 
275
275
577
0
575
568
815
0
812
814
918
0
845
823
825
942
845
1,698
1,708
1,868
1,868
1,873
1,883
1,362
1,362
1,322
1,100
1,132
1,132
1,062
1,063
33
0
0
1,132
33
1,028
1,028
1,028
1,028
1,028
1,028
1,028
33
483
483
483
225
888
928
1,346
0
896
896
1,346
896
1,346
1,346
1,346
1,346
1,346
896
450
450
450
450
450
2,414
275
0
0
0
0
0
0
0
50
0
0
0
0
0
97
0
104
0
124
0
130
143
139
0
110
70
60
0
60
60
606006070110013914313001240104097000005000000002752,4144504504504504508961,3461,3461,3461,3461,3468961,34689689601,346928888225483483483331,0281,0281,0281,0281,0281,0281,028331,13200331,0631,0621,1321,1321,1001,3221,3621,3621,8831,8731,8681,8681,7081,698845942825823845091881481208155685750577275275
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,414
544
0
0
0
0
0
0
0
50
0
0
0
0
0
0
0
0
0
0
130
135
143
139
110
70
70
60
60
60
60
60606060707011013914313513000000000005000000005442,4140000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
186
107
117
241
389
220
267
573
631
581
677
1,337
1,109
1,145
1,300
434
618
829
1,026
1,231
1,253
1,276
1,522
1,215
1,375
1,432
1,476
1,522
1,692
1,762
1,863
547
467
540
511
281
287
270
260
219
171
259
273
271
270
287
233
252
287
229
231
234
234
253
307
858
389
442
341
426
447
526
696
829
974
1,144
1,350
1,715
472
1,294
1,203
1,627
209
251
252
1,752
221
237
237
234
234
1,503
1,503
1,012
159
162
154
102
102
118
115
119
119
125
128
133
147
156
1561471331281251191191151181021021541621591,0121,5031,5032342342372372211,7522522512091,6271,2031,2944721,7151,3501,1449748296965264474263414423898583072532342342312292872522332872702712732591712192602702872815115404675471,8631,7621,6921,5221,4761,4321,3751,2151,5221,2761,2531,2311,0268296184341,3001,1451,1091,337677581631573267220389241117107186
       Other Current Liabilities 
186
107
117
0
241
220
267
0
573
581
677
2,279
1,109
1,145
1,300
1,337
1,109
829
1,026
1,231
1,231
1,276
1,522
1,470
1,470
1,711
1,998
1,846
1,911
2,717
3,023
1,762
229
243
1,846
1,762
833
788
805
710
710
820
877
777
365
371
365
815
360
810
366
372
822
813
804
19
19
28
19
19
19
469
19
10
10
10
81
105
967
104
105
1,418
1,418
1,445
1,493
0
1,531
1,704
1,778
0
1,860
707
790
0
1,012
993
1,111
0
1,231
1,273
1,351
0
1,439
1,650
1,782
0
2,048
2,180
2,1802,04801,7821,6501,43901,3511,2731,23101,1119931,01207907071,86001,7781,7041,53101,4931,4451,4181,41810510496710581101010194691919192819198048138223723668103608153653713657778778207107108057888331,7621,8462432291,7623,0232,7171,9111,8461,9981,7111,4701,4701,5221,2761,2311,2311,0268291,1091,3371,3001,1451,1092,27967758157302672202410117107186
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
775
756
756
769
776
783
772
778
0
698
1,719
1,446
1,287
2,345
2,578
2,609
2,674
2,739
2,804
2,870
2,986
3,001
3,066
3,131
2,139
3,198
1,058
1,058
0
1,058
1,058
1,058
0
1,058
1,058
1,058
1,136
1,136
1,149
1,155
104
1,162
1,175
1,182
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,0581,0581,0581,0581,0581,0581,0581,0581,0581,0581,0581,1821,1751,1621041,1551,1491,1361,1361,0581,0581,05801,0581,0581,05801,0581,0583,1982,1393,1313,0663,0012,9862,8702,8042,7392,6742,6092,5782,3451,2871,4461,71969807787727837767697567567750000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,287
1,422
1,516
1,551
1,616
1,681
1,746
1,812
1,928
1,943
2,008
2,073
2,139
204
0
0
0
0
0
0
0
0
0
0
78
85
91
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000091857800000000002042,1392,0732,0081,9431,9281,8121,7461,6811,6161,5511,5161,4221,2870000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
0
0
0
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
1,058
0
1,058
0
0
0
0
1,058
1,058
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,0581,05800001,05801,0581,0581,0581,0581,0581,0581,0581,0581,0581,0581,0580001,0581,0581,0581,0581,0581,0581,0581,0581,0580000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
230
211
211
224
231
238
245
251
251
251
272
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000100000000000002722512512512452382312242112112300000000000000000000000000000000000000000000
> Total Stockholder Equity
2,635
2,989
2,021
2,868
2,868
2,806
2,230
1,512
1,512
980
696
-633
-582
-569
-799
-633
-582
-929
-1,314
-1,796
-1,796
-2,007
-2,294
-1,662
-1,662
-2,223
-2,370
-2,384
-2,532
-2,505
-2,892
-1,073
0
0
-2,384
-1,073
-842
-904
-692
-848
-848
-1,069
-1,276
71
-169
470
195
37
-208
-620
-654
0
-797
-1,194
-1,832
-2,238
-2,238
-1,762
-2,110
-832
13,067
11,337
10,196
8,594
6,755
4,844
3,493
2,723
2,723
12,828
12,218
8,161
8,161
3,962
3,444
-150
-150
-1,127
102
-1,005
-1,005
-1,209
576
4,674
4,674
2,225
1,069
1,035
1,035
-1,228
-1,299
-1,695
-1,695
-2,344
-2,606
-2,860
-2,184
-2,342
-2,342-2,184-2,860-2,606-2,344-1,695-1,695-1,299-1,2281,0351,0351,0692,2254,6744,674576-1,209-1,005-1,005102-1,127-150-1503,4443,9628,1618,16112,21812,8282,7232,7233,4934,8446,7558,59410,19611,33713,067-832-2,110-1,762-2,238-2,238-1,832-1,194-7970-654-620-20837195470-16971-1,276-1,069-848-848-692-904-842-1,073-2,38400-1,073-2,892-2,505-2,532-2,384-2,370-2,223-1,662-1,662-2,294-2,007-1,796-1,796-1,314-929-582-633-799-569-582-6336969801,5121,5122,2302,8062,8682,8682,0212,9892,635
   Common Stock
101
102
102
105
105
111
113
115
115
120
121
122
137
172
172
122
137
175
175
178
178
182
182
183
183
198
201
201
201
250
250
319
320
336
201
319
380
396
396
398
398
400
402
412
413
430
436
440
446
450
456
459
459
462
463
465
465
490
495
516
518
519
522
537
534
534
534
534
534
534
534
534
534
534
534
534
534
558
558
558
558
558
558
559
559
559
559
559
559
559
559
0
559
559
559
0
559
559
55955905595595590559559559559559559559559558558558558558558534534534534534534534534534534534534534537522519518516495490465465463462459459456450446440436430413412402400398398396396380319201336320319250250201201201198183183182182178178175175137122172172137122121120115115113111105105102102101
   Retained Earnings -72,955-72,797-72,415-72,161-71,899-71,250-71,250-70,854-70,783-68,520-68,520-68,486-67,330-64,881-64,881-67,638-69,399-69,195-69,195-68,088-69,317-67,973-67,973-64,379-63,861-59,662-59,662-50,779-50,169-61,338-61,338-60,568-59,217-57,126-55,230-53,815-51,727-49,718-63,242-62,379-61,615-59,437-59,437-60,907-58,013-57,5090-57,026-56,702-56,013-55,419-54,947-53,882-53,432-53,132-53,894-53,594-53,089-53,089-52,831-53,185-52,643-50,501-47,48700-50,501-48,883-48,496-47,745-47,487-47,473-47,214-45,793-45,793-46,335-46,047-45,574-45,574-44,696-44,271-42,028-41,488-43,283-42,953-42,028-41,488-40,137-39,614-37,4600-36,313-35,201-30,7980-29,360-28,097-24,528
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,847
54,663
0
0
0
0
0
0
0
0
56,734
58,586
59,363
59,770
61,894
62,142
62,347
62,731
63,617
63,347
63,527
63,527
63,527
68,232
62,463
62,463
67,289
67,289
67,289
67,289
67,289
67,289
67,632
0
67,632
67,632
67,632
67,632
68,996
68,996
68,996
0
0
0
0
0
0
0
0
0
0
0
0
00000000000068,99668,99668,99667,63267,63267,63267,632067,63267,28967,28967,28967,28967,28967,28962,46362,46368,23263,52763,52763,52763,34763,61762,73162,34762,14261,89459,77059,36358,58656,7340000000054,66353,847000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000-330-13800000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
27,062
30,984
31,279
0
33,561
38,007
38,543
0
38,857
40,474
40,712
40,733
41,309
42,212
42,312
40,733
41,309
43,167
43,207
43,600
43,600
43,858
43,859
43,948
43,948
44,793
44,902
44,902
45,012
45,741
45,741
49,109
0
0
44,902
49,109
51,292
51,509
51,528
51,843
51,692
51,974
52,119
52,726
52,785
53,847
54,663
54,984
55,316
55,589
55,873
0
56,231
56,357
57,472
0
55,676
58,305
58,716
61,011
61,084
61,289
61,535
62,229
62,289
62,469
62,469
0
62,469
61,405
61,405
0
66,231
66,231
66,231
0
66,231
66,574
66,574
0
66,574
66,574
66,574
0
67,938
67,938
67,938
0
67,938
68,996
68,996
0
68,996
68,996
67,938
0
69,555
70,613
70,61369,555067,93868,99668,996068,99668,99667,938067,93867,93867,938066,57466,57466,574066,57466,57466,231066,23166,23166,231061,40561,40562,469062,46962,46962,28962,22961,53561,28961,08461,01158,71658,30555,676057,47256,35756,231055,87355,58955,31654,98454,66353,84752,78552,72652,11951,97451,69251,84351,52851,50951,29249,10944,9020049,10945,74145,74145,01244,90244,90244,79343,94843,94843,85943,85843,60043,60043,20743,16741,30940,73342,31242,21241,30940,73340,71240,47438,857038,54338,00733,561031,27930,98427,062



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1
Gross Profit-1-1
 
Operating Income (+$)
Gross Profit-1
Operating Expense-703
Operating Income-703-704
 
Operating Expense (+$)
Research Development10
Selling General Administrative693
Selling And Marketing Expenses1
Operating Expense703704
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-703
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,165-241
EBIT - interestExpense = -1,165
-2,330
-1,165
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-1,165-1,165
Earnings Before Interest and Taxes (EBITDA)-1,164
 
After tax Income (+$)
Income Before Tax-1,165
Tax Provision-0
Net Income From Continuing Ops-1,165-1,165
Net Income-1,165
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses703
Total Other Income/Expenses Net-4620
 

Technical Analysis of Manhattan Scients
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Manhattan Scients. The general trend of Manhattan Scients is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Manhattan Scients's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Manhattan Scients.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.0008 < 0.0008 < 0.0008.

The bearish price targets are: 0.0007 > 0.0007 > 0.0007.

Tweet this
Manhattan Scients Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Manhattan Scients. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Manhattan Scients Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Manhattan Scients. The current macd is -0.000030.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Manhattan Scients price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Manhattan Scients. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Manhattan Scients price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Manhattan Scients Daily Moving Average Convergence/Divergence (MACD) ChartManhattan Scients Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Manhattan Scients. The current adx is 16.23.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Manhattan Scients shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Manhattan Scients Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Manhattan Scients. The current sar is 0.00103464.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Manhattan Scients Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Manhattan Scients. The current rsi is 45.85. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Manhattan Scients Daily Relative Strength Index (RSI) ChartManhattan Scients Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Manhattan Scients. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Manhattan Scients price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Manhattan Scients Daily Stochastic Oscillator ChartManhattan Scients Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Manhattan Scients. The current cci is -54.54545455.

Manhattan Scients Daily Commodity Channel Index (CCI) ChartManhattan Scients Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Manhattan Scients. The current cmo is -10.64040106.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Manhattan Scients Daily Chande Momentum Oscillator (CMO) ChartManhattan Scients Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Manhattan Scients. The current willr is -66.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Manhattan Scients is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Manhattan Scients Daily Williams %R ChartManhattan Scients Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Manhattan Scients.

Manhattan Scients Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Manhattan Scients. The current atr is 0.00011557.

Manhattan Scients Daily Average True Range (ATR) ChartManhattan Scients Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Manhattan Scients. The current obv is -12,491,145.

Manhattan Scients Daily On-Balance Volume (OBV) ChartManhattan Scients Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Manhattan Scients. The current mfi is 91.83.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Manhattan Scients Daily Money Flow Index (MFI) ChartManhattan Scients Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Manhattan Scients.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Manhattan Scients Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Manhattan Scients based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.850
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Manhattan Scients with someone you think should read this too:
  • Are you bullish or bearish on Manhattan Scients? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Manhattan Scients? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Manhattan Scients

I send you an email if I find something interesting about Manhattan Scients.


Comments

How you think about this?

Leave a comment

Stay informed about Manhattan Scients.

Receive notifications about Manhattan Scients in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.